Pacific Biosciences of California Inc. buy Jefferies Financial Group Inc.
Start price
03.06.24
/
50%
€1.75
Target price
03.06.25
€3.69
Performance (%)
-13.28%
Price
19.07.24
€1.52
Summary
This prediction is currently active. The prediction for Pacific Biosciences of California Inc. disappoints with a performance of -13.28%. This prediction currently runs until 03.06.25. The prediction end date can be changed by Jefferies_Financial_ at any time. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Pacific Biosciences of California Inc. | -0.938% | -0.938% |
| iShares Core DAX® | -3.033% | -0.013% |
| iShares Nasdaq 100 | -3.554% | -2.546% |
| iShares Nikkei 225® | -3.938% | 2.183% |
| iShares S&P 500 | -1.517% | -0.882% |
Comments by Jefferies_Financial_ for this prediction
In the thread Pacific Biosciences of California Inc. diskutieren
Pacific Biosciences of California, Inc. (NASDAQ: PACB) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $4.00 price target on the stock.
Ratings data for PACB provided by MarketBeat